CD200 and plasma cell myeloma: Douds et al. and Alapat et al. observed CD200 positivity in approximately 70% of plasma cell myeloma (PCM) cases, suggesting the possibility of CD200 expression as a diagnostic and prognostic factor for PCM [105,106].